nach oben

Community Mental Health Journal

Erschienen in:

29.10.2018 | Brief Report

Abuse and Effects of Salvia divinorum in a Sample of Patients Hospitalized for Substance Dependence

verfasst von: Antoine Karam, Aida Said, Chafika Assaad, Souheil Hallit, Georges Haddad, Dory Hachem, Francois Kazour

Erschienen in: Community Mental Health Journal | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

The study goal is to document the prevalence of salvia use among patients admitted for detoxification of other illicit drug use and to determine its effect. This cross-sectional study included 47 heavy drug users who were admitted for detoxification of other illicit drug abuse at a psychiatric hospital in Lebanon. The prevalence of salvia use was 66%. The salvia effect started and dissipated rapidly (15 min). No significant difference was found between salvia and non-salvia users in terms of affect, cognition and somaesthesia subscales of the Hallucinogen Rating Scale. Ratings of intensity and volition subscales were higher in non-salvia users than salvia users, while perception score was higher in users. Salvia use was correlated with perceptual alteration and hallucinogenic effects.

Addy, P. H. (2012). Acute and post-acute behavioral and psychological effects of salvinorin A in humans. Psychopharmacology (Berlin), 220(1), 195–204.CrossRef

Addy, P. H., Garcia-Romeu, A., Metzger, M., & Wade, J. (2015). The subjective experience of acute, experimentally-induced Salvia divinorum inebriation. Journal of Psychopharmacology, 29(4), 426–435.CrossRefPubMed

Albertson, D. N., & Grubbs, L. E. (2009). Subjective effects of Salvia divinorum: LSD- or marijuana-like? Journal of Psychoactive Drugs, 41(3), 213–217.CrossRefPubMed

Ansonoff, M. A., Zhang, J., Czyzyk, T., Rothman, R. B., Stewart, J., Xu, H., et al. (2006). Antinociceptive and hypothermic effects of salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice. Journal of Pharmacology and Experimental Therapeutics, 318(2), 641–648.CrossRefPubMed

Appel, J., & Kim-Appel, D. (2007). The rise of a new psychoactive agent: Salvia divinorum. International Journal of Mental Health and Addiction, 5(3), 248–253.CrossRef

Baggott, M. J., Erowid, E., Erowid, F., Galloway, G. P., & Mendelson, J. (2010). Use patterns and self-reported effects of Salvia divinorum: An internet-based survey. Drug and Alcohol Dependence, 111(3), 250–256.CrossRefPubMed

Chavkin, C., Sud, S., Jin, W., Stewart, J., Zjawiony, J. K., Siebert, D. J., et al. (2004). Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum is a highly efficacious kappa-opioid receptor agonist: Structural and functional considerations. Journal of Pharmacology and Experimental Therapeutics, 308(3), 1197–1203.CrossRefPubMed

Cunningham, C. W., Rothman, R. B., & Prisinzano, T. E. (2011). Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A. Pharmacological Reviews, 63(2), 316–347.CrossRefPubMedPubMedCentral

El-Khoury, J., & Sahakian, N. (2015). The association of Salvia divinorum and psychotic disorders: A review of the literature and case series. Journal Psychoactive Drugs, 47(4), 286–292.CrossRef

Featherstone, R. E., Liang, Y., Saunders, J. A., Tatard-Leitman, V. M., Ehrlichman, R. S., & Siegel, S. J. (2012). Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice. Neurobiology of Disease, 47(3), 338–346.CrossRefPubMed

González, D., Riba, J., Bouso, J. C., Gómez-Jarabo, G., & Barbanoj, M. J. (2006). Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug and Alcohol Dependence, 85(2), 157–162.CrossRefPubMed

Hooker, J. M., Xu, Y., Schiffer, W., Shea, C., Carter, P., & Fowler, J. S. (2008). Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans. Neuroimage, 41(3), 1044–1050.CrossRefPubMedPubMedCentral

Johnson, M. W., MacLean, K. A., Reissig, C. J., Prisinzano, T. E., & Griffiths, R. R. (2011). Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum. Drug and Alcohol Dependence, 115(1–2), 150–155.CrossRefPubMed

Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261–276.CrossRefPubMed

Kazour, F., Soufia, M., Rohayem, J., & Richa, S. (2016). Suicide risk of heroin dependent subjects in Lebanon. Community Mental Health Journal, 52(5), 589–596.CrossRefPubMed

Kelly, B. C. (2011). Legally tripping: A qualitative profile of Salvia divinorum use among young adults. Journal of Psychoactive Drugs, 43(1), 46–54.CrossRefPubMed

Khey, D. N., Miller, B. L., & Griffin, O. H. (2008). Salvia divinorum use among a college student sample. Journal of Drug Education, 38(3), 297–306.CrossRefPubMed

Lange, J. E., Reed, M. B., Croff, J. M., & Clapp, J. D. (2008). College student use of Salvia divinorum. Drug and Alcohol Dependence, 94(1–3), 263–266.CrossRefPubMedPubMedCentral

MacLean, K. A., Johnson, M. W., Reissig, C. J., Prisinzano, T. E., & Griffiths, R. R. (2013). Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects. Psychopharmacology (Berline), 226(2), 381–392.CrossRef

McLellan, A. T., Luborsky, L., Woody, G. E., & O’Brien, C. P. (1980). An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. The Journal of Nervous and Mental Disease, 168(1), 26–33.CrossRefPubMed

Miller, B. L., Griffin, O. H., Gibson, C. L., & Khey, D. N. (2009). Trippin’on Sally D: Exploring predictors of Salvia divinorum experimentation. Journal of Criminal Justice, 37(4), 396–403.CrossRef

Nyi, P. P., Lai, E. P., Lee, D. Y., Biglete, S. A., Torrecer, G. I., & Anderson, I. B. (2010). Influence of age on Salvia divinorum use: Results of an Internet survey. Journal of Psychoactive Drugs, 42(3), 385–392.CrossRefPubMed

Perron, B. E., Ahmedani, B. K., Vaughn, M. G., Glass, J. E., Abdon, A., & Wu, L. T. (2012). Use of Salvia divinorum in a nationally representative sample. The American Journal of Drug and Alcohol Abuse, 38(1), 108–113.CrossRefPubMed

Prisinzano, T. E. (2005). Psychopharmacology of the hallucinogenic sage Salvia divinorum. Life Sciences, 78(5), 527–531.CrossRefPubMed

Ranganathan, M., Schnakenberg, A., Skosnik, P. D., Cohen, B. M., Pittman, B., Sewell, R. A., et al. (2012). Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the kappa opioid agonist salvinorin A in humans. Biological Psychiatry, 72(10), 871–879.CrossRefPubMedPubMedCentral

Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., et al. (2002). Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist. Proceedings of the National Academy of Sciences, 99(18), 11934–11939.CrossRef

Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59(Suppl 20), 22–33 (quiz 4–57).PubMed

Siebert, D. J. (1994). Salvia divinorum and salvinorin A: New pharmacologic findings. Journal of Ethnopharmacology, 43(1), 53–56.CrossRefPubMed

Strassman, R. J., Qualls, C. R., Uhlenhuth, E. H., & Kellner, R. (1994). Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry, 51(2), 98–108.CrossRefPubMed

Substance Abuse and Mental Health Services Administration, Office of Applied Studies (SAMHSA). (2008). The NSDUH report: Use of specific hallucinogens: 2006. Retreived from http://www.oas.samhsa.gov/2k8/hallucinogens/hallucinogens.htm

Sumnall, H. R., Measham, F., Brandt, S. D., & Cole, J. C. (2011). Salvia divinorum use and phenomenology: Results from an online survey. Journal of Psychopharmacology, 25(11), 1496–1507.CrossRefPubMed

Valdes, L. J. 3rd (1994). Salvia divinorum and the unique diterpene hallucinogen, salvinorin (divinorin) A. Journal of Psychoactive Drugs, 26(3), 277–283.CrossRefPubMed

Wu, L. T., Woody, G. E., Yang, C., Li, J. H., & Blazer, D. G. (2011). Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers. Substance Abuse and Rehabilitation, 2011(2), 53–68.CrossRefPubMed

Zawilska, J. B., & Wojcieszak, J. (2013). Salvia divinorum: From Mazatec medicinal and hallucinogenic plant to emerging recreational drug. Human Psychopharmacology, 28(5), 403–412.CrossRefPubMed

Titel: Abuse and Effects of Salvia divinorum in a Sample of Patients Hospitalized for Substance Dependence
verfasst von: Antoine Karam
Aida Said
Chafika Assaad
Souheil Hallit
Georges Haddad
Dory Hachem
Francois Kazour
Publikationsdatum: 29.10.2018
Verlag: Springer US
Erschienen in: Community Mental Health Journal / Ausgabe 4/2019
Print ISSN: 0010-3853
Elektronische ISSN: 1573-2789
DOI: https://doi.org/10.1007/s10597-018-0347-4

Neu im Fachgebiet Psychiatrie

23.04.2024 | Demenz | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abuse and Effects of Salvia divinorum in a Sample of Patients Hospitalized for Substance Dependence

Abstract

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

An Assessment of The New York State Behavioral Health System’s Readiness to Transition to Medicaid Managed Care

Development and Implementation of Psychiatric Services in a Student-Operated Clinic

Losing to Gain: The Effects of a Healthy Lifestyle Intervention on the Physical and Psychosocial Well-being of Clients in a Community-based Mental Health Setting

Beliefs Supporting Violence, Attitudes and Aggressive Behavior Among School Adolescents in Rural Delhi

Predictors of Mental Health Recovery in Homeless Adults with Mental Illness

Experiences and Perceptions of Abused Turkish Women Regarding Violence Against Women

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie